Thus, all these findings provide a convincible validation of the enhancement of HCC growth and maintenance of resisting cell apoptosis under the control of pseudogene UBE2MP1 through modulating the miR-145-5p/RGS3 axis. The gene discussed is UBE2MP1; the disease is hepatocellular carcinoma.